We just received data on a new analyst forecast for $CDNA. William Blair gave a rating of 'Market Perform' for $CDNA.
$CDNA Analyst Ratings
Wall Street analysts have issued reports on $CDNA in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Craig-Hallum issued a "Buy" rating on 07/18/2025
- Stephens & Co. issued a "Overweight" rating on 05/05/2025
- Goldman Sachs issued a "Buy" rating on 04/17/2025
To track analyst ratings and price targets for $CDNA, check out Quiver Quantitative's $CDNA forecast page.
$CDNA Price Targets
Multiple analysts have issued price targets for $CDNA recently. We have seen 5 analysts offer price targets for $CDNA in the last 6 months, with a median target of $26.0.
Here are some recent targets:
- Brandon Couillard from Wells Fargo set a target price of $14.0 on 08/08/2025
- Connor Chamberlain from Craig-Hallum set a target price of $26.0 on 07/18/2025
- Mason Carrico from Stephens & Co. set a target price of $40.0 on 05/05/2025
- Yi Chen from HC Wainwright & Co. set a target price of $25.0 on 05/05/2025
- Matthew Sykes from Goldman Sachs set a target price of $26.0 on 04/17/2025
$CDNA Insider Trading Activity
$CDNA insiders have traded $CDNA stock on the open market 13 times in the past 6 months. Of those trades, 0 have been purchases and 13 have been sales.
Here’s a breakdown of recent trading of $CDNA stock by insiders over the last 6 months:
- WILLIAM A HAGSTROM has made 0 purchases and 2 sales selling 49,391 shares for an estimated $909,330.
- CHRISTINE COURNOYER has made 0 purchases and 2 sales selling 45,836 shares for an estimated $700,951.
- PETER MAAG has made 0 purchases and 3 sales selling 33,281 shares for an estimated $607,046.
- GEORGE BICKERSTAFF sold 20,000 shares for an estimated $367,102
- HANNAH VALANTINE sold 10,570 shares for an estimated $202,565
- JEFFREY ADAM NOVACK (Secretary and General Counsel) has made 0 purchases and 3 sales selling 6,300 shares for an estimated $90,267.
- ABHISHEK JAIN (Chief Financial Officer) sold 265 shares for an estimated $4,695
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CDNA Hedge Fund Activity
We have seen 89 institutional investors add shares of $CDNA stock to their portfolio, and 137 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- NEXT CENTURY GROWTH INVESTORS LLC added 850,580 shares (+309.4%) to their portfolio in Q2 2025, for an estimated $16,620,333
- POINT72 ASSET MANAGEMENT, L.P. removed 465,665 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $8,265,553
- DIVISADERO STREET CAPITAL MANAGEMENT, LP removed 454,438 shares (-97.3%) from their portfolio in Q2 2025, for an estimated $8,879,718
- BLACKROCK, INC. removed 416,379 shares (-8.2%) from their portfolio in Q2 2025, for an estimated $8,136,045
- ARROWMARK COLORADO HOLDINGS LLC added 396,714 shares (+123.0%) to their portfolio in Q2 2025, for an estimated $7,751,791
- DRIEHAUS CAPITAL MANAGEMENT LLC removed 348,772 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $6,815,004
- RUSSELL INVESTMENTS GROUP, LTD. removed 335,982 shares (-56.5%) from their portfolio in Q2 2025, for an estimated $6,565,088
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
